Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner

Chen, Peiwen, Huang, Yujie, Bong, Rosabel, Ding, Yanping, Song, Nan, Wang, Xiaofeng, Song, Xiaomin, Luo, Yongzhang·2011·Clinical Cancer Research

Published version of a preprint

Abstract

Purpose: Elevated numbers of tumor-associated macrophages (TAM) in the tumor microenvironment are often correlated with poor prognosis in melanoma. However, the mechanisms by which TAMs modulate melanoma growth are still poorly understood. This study was aimed at examining the function and mechanism of TAM-derived adrenomedullin (ADM) in angiogenesis and melanoma growth. Experimental Design: We established in vitro and in vivo models to investigate the relationship between TAMs and ADM in melanoma, the role and mechanism of ADM in TAM-induced angiogenesis and melanoma growth. The clinical significance of ADM and its receptors was evaluated using melanoma tissue microarrays. Results: ADM was expressed by infiltrating TAMs in human melanoma, and its secretion from macrophages was upregulated upon coculture with melanoma cells, or with melanoma cells conditioned media. Meanwhile, TAMs enhanced endothelial cell migration and tubule formation and also increased B16/F10 tumor growth. Neutralizing ADM antibody and ADM receptor antagonist, AMA, attenuated TAM-induced angiogenesis in vitro and melanoma growth in vivo, respectively. Furthermore, ADM promoted angiogenesis and melanoma growth via both the paracrine effect, mediated by the endothelial nitric oxide synthase signaling pathway, and the autocrine effect, which stimulated the polarization of macrophages toward an alternatively activated (M2) phenotype. Finally, immunofluorescence analysis on human melanomas showed that the expression of ADM in TAMs and its receptors was greatly increased compared with adjacent normal skins. Conclusion: Our study reveals a novel mechanism that TAMs enhance angiogenesis and melanoma growth via ADM and provides potential targets for melanoma therapies. Clin Cancer Res; 17(23); 7230–9. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-11-1354

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 38

  1. Kuphal, 2009, Recent progress in understanding the pathology of malignant melanoma, J Pathol, 219, 400, 10.1002/path.2617 · DOI
  2. Van der Bij, 2005, The role of macrophages in tumor development, Cell Oncol, 27, 203
  3. Pollard, 2004, Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer, 4, 71, 10.1038/nrc1256 · DOI · Paper page
  4. Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007 · DOI · Paper page
  5. Watkins, 2007, IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo, J Immunol, 178, 1357, 10.4049/jimmunol.178.3.1357 · DOI · Paper page
  6. Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 · DOI · Paper page
  7. Zudaire, 2003, Adrenomedullin and cancer, Regul Pept, 112, 175, 10.1016/S0167-0115(03)00037-5 · DOI · Paper page
  8. Bunton, 2004, The clinical relevance of adrenomedullin: a promising profile?, Pharmacol Ther, 103, 179, 10.1016/j.pharmthera.2004.07.002 · DOI
  9. Martinez, 1997, Expression of adrenomedullin and its receptor in normal and malignant human skin: a potential pluripotent role in the integument, Endocrinology, 138, 5597, 10.1210/endo.138.12.5622 · DOI
  10. Martinez, 2002, The effects of adrenomedullin overexpression in breast tumor cells, J Natl Cancer Inst, 94, 1226, 10.1093/jnci/94.16.1226 · DOI
  11. Oehler, 2003, Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer, Br J Cancer, 89, 1927, 10.1038/sj.bjc.6601397 · DOI
  12. Ouafik, 2002, Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo, Am J Pathol, 160, 1279, 10.1016/S0002-9440(10)62555-2 · DOI
  13. Ishikawa, 2003, Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis, Oncogene, 22, 1238, 10.1038/sj.onc.1206207 · DOI
  14. Kaafarani, 2009, Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice, FASEB J, 23, 3424, 10.1096/fj.08-127852 · DOI
  15. Ramachandran, 2009, The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment, PLoS One, 4, e7502, 10.1371/journal.pone.0007502 · DOI
  16. Kubo, 1998, Production of adrenomedullin in macrophage cell line and peritoneal macrophage, J Biol Chem, 273, 16730, 10.1074/jbc.273.27.16730 · DOI · Paper page
  17. Wong, 2005, Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line, Endocrinology, 146, 1321, 10.1210/en.2004-1080 · DOI
  18. Cejudo-Martin, 2002, Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients, Hepatology, 36, 1172, 10.1053/jhep.2002.36371 · DOI
  19. Zhu, 2008, Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages, J Biol Chem, 283, 22930, 10.1074/jbc.M801408200 · DOI · Paper page
  20. Huang, 2006, The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin, Blood, 107, 3564, 10.1182/blood-2005-07-2961 · DOI · Paper page
  21. Stout, 2005, Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences, J Immunol, 175, 342, 10.4049/jimmunol.175.1.342 · DOI · Paper page
  22. Makitie, 2001, Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma, Invest Ophthalmol Vis Sci, 42, 1414
  23. Zeisberger, 2006, Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach, Br J Cancer, 95, 272, 10.1038/sj.bjc.6603240 · DOI · Paper page
  24. Bottazzi, 1992, Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma, J Immunol, 148, 1280, 10.4049/jimmunol.148.4.1280 · DOI · Paper page
  25. Michaylira, 2006, Hypoxic microenvironment as a cradle for melanoma development and progression, Cancer Biol Ther, 5, 476, 10.4161/cbt.5.5.2749 · DOI
  26. Nikitenko, 2003, Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia, FASEB J, 17, 1499, 10.1096/fj.02-0993fje · DOI
  27. Kim, 2003, Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells, FASEB J, 17, 1937, 10.1096/fj.02-1209fje · DOI
  28. Fernandez-Sauze, 2004, Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors, Int J Cancer, 108, 797, 10.1002/ijc.11663 · DOI
  29. Min, 2007, Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice, Blood, 109, 1495, 10.1182/blood-2006-06-029298 · DOI
  30. Nguyen, 2006, Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism, Proc Natl Acad Sci U S A, 103, 6530, 10.1073/pnas.0511011103 · DOI · Paper page
  31. Pi, 2009, SDF-1alpha stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration, Proc Natl Acad Sci U S A, 106, 5675, 10.1073/pnas.0809568106 · DOI
  32. Fukumura, 2001, Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability, Proc Natl Acad Sci U S A, 98, 2604, 10.1073/pnas.041359198 · DOI · Paper page
  33. Berenguer, 2008, Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates ‘neuroendocrine phenotype' in LNCaP prostate tumor cells, Oncogene, 27, 506, 10.1038/sj.onc.1210656 · DOI
  34. Kato, 1997, Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells, Endocrinology, 138, 2615, 10.1210/endo.138.6.5197 · doi:10.1210/endo.138.6.5197 · Paper page
  35. Oehler, 2002, Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis, Oncogene, 21, 2815, 10.1038/sj.onc.1205374 · DOI
  36. Brekhman, 2011, Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2, FASEB J, 25, 155, 10.1096/fj.10-162677 · DOI
  37. Balkwill, 2004, Cancer: an inflammatory link, Nature, 431, 405, 10.1038/431405a · DOI · Paper page
  38. Movahedi, 2010, Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes, Cancer Res, 70, 5728, 10.1158/0008-5472.CAN-09-4672 · DOI · Paper page

Cited by

See all 227

Metadata

Authors
Chen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., Song, X., & Luo, Y.
Venue
Clinical Cancer Research
Published
2011-11-30
Volume
17
Issue
23
Pages
7230-7239
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2144370960
Cited by
227
References
12
FWCI
5.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-11-1354
The paper
Chen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., Song, X., & Luo, Y. (2011). Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-1354

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.